News Author: Jennifer Smith Publish date: September 26, 2019
Older age, advanced stage disease, having a mismatched unrelated donor, and receiving peripheral blood stem cells from an unrelated donor were link...
Article Author: Jennifer Smith Publish date: September 23, 2019
The Multiple Myeloma Research Foundation, Fox Chase Cancer Center, the Oncology Institute of Hope and Innovation, and AAHPM Quarterly all made new ...
News Author: Jennifer Smith Publish date: September 22, 2019
BOSTON – Selinexor plus lenalidomide and dexamethasone proved particularly active in lenalidomide-naive patients.
News Author: Jennifer Smith Publish date: September 20, 2019
BOSTON – Adding daratumumab to bortezomib, lenalidomide, and dexamethasone improved responses and minimal residual disease negativity.
News Author: Jennifer Smith Publish date: September 19, 2019
BOSTON – The overall survival advantage with elotuzumab was observed in all prespecified patient subgroups, including older patients, those with ad...
News Author: Jennifer Smith Publish date: September 19, 2019
BOSTON – Three of four patients who had failed a prior CAR T-cell therapy achieved a stringent complete response after CT103A.
News Author: Jennifer Smith Publish date: September 19, 2019
BOSTON – Melflufen plus dexamethasone produced similar response rates in patients with and without extramedullary disease.
Video Author: Jennifer Smith Publish date: September 18, 2019
Researchers are conducting phase 2 trials comparing patients who receive all posttransplant care at home with patients treated in the hospital or i...
News Author: Jennifer Smith Publish date: September 9, 2019
One researcher will examine burnout among physician assistants working in oncology.
News Author: Jennifer Smith Publish date: September 8, 2019
The various programs include efforts to build a registry for patients with sickle cell disease and ways to optimize the use of hydroxyurea in child...
News Author: Jennifer Smith Publish date: September 5, 2019
Data from two clinical trials of idelalisib showed no significant difference in overall survival between patients with and without complex karyotyp...
News Author: Jennifer Smith Publish date: August 28, 2019
Nivolumab produced an intracranial response rate of 12% in patients with clear cell renal cell carcinoma and previously untreated brain metastases....
News Author: Jennifer Smith Publish date: August 27, 2019
In a single-center study, deferasirox plus deferoxamine significantly decreased cardiac iron and serum ferritin, but deferasirox alone did not.
Article Author: Jennifer Smith Publish date: August 26, 2019
Investigators received a National Institutes of Health R21 grant and CancerLinQ Discovery Research Support Grants.
News Author: Jennifer Smith Publish date: August 23, 2019
A 47-year-old woman developed severe lipodystrophy after receiving pembrolizumab to treat metastatic melanoma.
